| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 791 |
| 1 | LANSOPRAZOLE | 790 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 789 |
| 3 | ESOMEPRAZOLE SODIUM | 789 |
| 4 | PANTOPRAZOLE SODIUM | 788 |
| 5 | DEXLANSOPRAZOLE | 786 |
| 6 | OMEPRAZOLE | 97 |
| 7 | FAMOTIDINE | 46 |
| 8 | PANTOPRAZOLE | 41 |
| 9 | LANSOPRAZOLE DELAYED RELEASE | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXLANSOPRAZOLE | 786 | 0.0216 |
| 1 | PANTOPRAZOLE SODIUM | 788 | 0.0070 |
| 2 | LANSOPRAZOLE | 790 | 0.0054 |
| 3 | ESOMEPRAZOLE SODIUM | 789 | 0.0047 |
| 4 | OMEPRAZOLE, SODIUM BICARBONATE | 2 | 0.0042 |
| 5 | ORPHENADRINE CITRATE | 2 | 0.0041 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 789 | 0.0038 |
| 7 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 2 | 0.0031 |
| 8 | OMEPRAZOLE AND SODIUM BICARBONATE | 7 | 0.0024 |
| 9 | OMEPRAZOLE MAGNESIUM | 791 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 791 |
| 1 | Histamine-2 Receptor Antagonist [EPC] | 64 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 55 |
| 3 | Benzodiazepine [EPC] | 24 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 22 |
| 5 | Loop Diuretic [EPC] | 21 |
| 6 | Corticosteroid [EPC] | 19 |
| 7 | Expectorant [EPC] | 18 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 16 |
| 9 | l-Thyroxine [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 791 | 0.0017 |
| 1 | Bismuth [EPC] | 5 | 0.0011 |
| 2 | Anti-coagulant [EPC] | 3 | 0.0005 |
| 3 | Vitamin D3 Analog [EPC] | 8 | 0.0005 |
| 4 | Aluminum Complex [EPC] | 7 | 0.0004 |
| 5 | Non-narcotic Antitussive [EPC] | 3 | 0.0003 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Chloride Channel Activator [EPC] | 2 | 0.0003 |
| 8 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0002 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 64 | 0.0002 |